Completed Clinical Trials

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

By April 24, 2017 No Comments


Leukemia|Lung Cancer|Malignant Mesothelioma|Myelodysplastic Syndromes|Primary Peritoneal Cavity Cancer

Estimated Enrollment: 22

Age Group: 18 Years to 120 Years   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: 06-085|P30CA008748|P01CA023766|MSKCC-06085

Study First Received: November 9, 2006

Last Updated: February 2, 2016

Estimated Primary Completion Date: June 2009


Primary Outcome Measures:

Safety|Immune Response

Sponsors and Collaborators:

Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI)|Innovive Pharmaceuticals

Website Link:

Leave a Reply

Call Now ButtonCall Now